Montreal Neurological Institute

Montreal, Quebec H3A 2B4

1 studies enrolling now · 22 studies all time

What they study most

ALS, Acute Brainstem/Cerebellar Syndrome, Acute Ischemic Stroke, Aggression, Agitation, Alzheimer Dementia, Amyotrophic Lateral Sclerosis, Anaplastic Astrocytoma, Cervical Spondylotic Myelopathy, DM1, Dementia, Dystrophy Myotonic

Studies at this site

• Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 — Enrolling by invitation
• FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS) — Running, not enrolling
• A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80 — Completed
• Global Study of Del-desiran for the Treatment of DM1 — Running, not enrolling
• EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) — Running, not enrolling
• An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) — Completed
• A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression — Stopped early
• Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) — Completed
• An Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation — Completed
• The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma — Stopped early
• Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) — Completed
• Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) — Completed
• Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation — Completed
• Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis — Completed
• Progesterone vs Placebo Therapy for Women With Epilepsy — Completed
• Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis — Completed
• Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) — Completed
• Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) — Completed
• Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients — Stopped early
• Talampanel for Amyotrophic Lateral Sclerosis (ALS) — Completed
• Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis — Completed
• Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke — Stopped early